{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T07:59:10Z","timestamp":1722931150274},"reference-count":36,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T00:00:00Z","timestamp":1329696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Interven Cardiology"],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:p><jats:bold>\n            <jats:italic>Background:<\/jats:italic>\n          <\/jats:bold>\n          <jats:italic> The aim was to ascertain the 1\u2010year clinical outcomes of 1,234 patients who underwent implantations of sirolimus\u2010eluting stents (SES) for acute myocardial infarction (MI) in the multinational e\u2010SELECT registry.<\/jats:italic><\/jats:p><jats:p><jats:bold>\n            <jats:italic>Methods:<\/jats:italic>\n          <\/jats:bold>\n          <jats:italic>Fifteen thousand and one hundred and forty\u2010seven patients treated with SES were entered in the e\u2010SELECT registry, of whom 1,234 presented within &lt;24 hours of onset of acute MI.<\/jats:italic><\/jats:p><jats:p><jats:bold>\n            <jats:italic>Results:<\/jats:italic>\n          <\/jats:bold>\n          <jats:italic>At 1 year, the rates of major adverse cardiac events (MACE) (5.5% vs. 4.8%; P = 0.28) were similarly low in the acute and no acute MI groups. The rates of definite\/probable stent thrombosis (ST) were higher in the acute MI group (2.1%vs; 0.88%, P &lt; 0.001). ST was a strong independent predictor of death at 1 year (HR 13.4; 95% CI 5.0, 36.0; P &lt; 0.001) and MI (HR 58.9; 95% CI 26.9, 129.1; P &lt; 0.001). Dual antiplatelet therapy (DAPT) compliance at 6 months was 96.0% in the acute MI versus 94.5% in the no acute MI group (P = 0.03).<\/jats:italic><\/jats:p><jats:p><jats:bold>\n            <jats:italic>Conclusion:<\/jats:italic>\n          <\/jats:bold>\n          <jats:italic> In selected patients presenting within &lt;24 hours of acute MI onset and highly compliant with DAPT, SES implantation was associated with similar rates of MACE, though higher rates of ST, as compared to no acute MI patients.<\/jats:italic><\/jats:p><jats:p><jats:bold>Condensed abstract\u2002<\/jats:bold> In the e\u2010SELECT registry which included 15,147 patients treated with sirolimus\u2010eluting stent (SES), we ascertained the 1\u2010year clinical outcomes of 1,234 patients who presented within &lt;24 hours of acute MI onset. In acute MI patients SES implantation was associated with similar rates of MACE, though higher rates of ST, as compared to no acute MI patients (MACE: 5.5% vs. 4.8%; P = 0.28; ST: 2.1 vs. 0.88%, P &lt; 0.001). (J Interven Cardiol 2012;25:253\u2013261)<\/jats:p>","DOI":"10.1111\/j.1540-8183.2011.00705.x","type":"journal-article","created":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T00:26:28Z","timestamp":1329783988000},"page":"253-261","source":"Crossref","is-referenced-by-count":1,"title":["One\u2010Year Clinical Outcomes after Sirolimus\u2010Eluting Coronary Stent Implantation for Acute Myocardial Infarction in the Worldwide e\u2010SELECT Registry"],"prefix":"10.1111","volume":"25","author":[{"given":"STEPHEN G.","family":"WORTHLEY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALEXANDRE","family":"ABIZAID","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ADRIAN","family":"BANNING","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANTONIO","family":"BARTORELLI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VLADIM\u00cdR","family":"D\u017dAV\u00cdk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"STEPHEN","family":"ELLIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RUNLIN","family":"GAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VICTOR","family":"LEGRAND","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PHILIP","family":"URBAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHRISTIAN","family":"SPAULDING","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the e\u2010SELECT investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,2,20]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"296","article-title":"2004 Writing Committee Members, Anbe DT, Kushner FG, Ornato JP, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 Focused Update of the ACC\/AHA 2004 Guidelines for the Management of Patients with ST\u2010Elevation Myocardial Infarction: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC\/AHA 2004 Guidelines for the Management of Patients with ST\u2010Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee","volume":"117","author":"Antman EM","year":"2008","journal-title":"Circulation"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.181940"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.17.2109"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062006"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.01.081"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062598"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810116"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.11.028"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.685313"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052711"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm402"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.17.2109"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.03.016"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.10.007"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801485"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn604"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60314-6"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067731"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp275"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.693739"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.144220"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.762047"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.618066"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn416"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.532242"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60441-4"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482"},{"key":"e_1_2_7_30_2","first-page":"271","volume-title":"Am Heart J","author":"Leibundgut G","year":"2009"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2009.04.003"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.07.016"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.842757"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.12.055"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV7I4A71"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2009.10.001"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.109.852178.109.852178"}],"container-title":["Journal of Interventional Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8183.2011.00705.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8183.2011.00705.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T09:41:15Z","timestamp":1697362875000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8183.2011.00705.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,20]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1111\/j.1540-8183.2011.00705.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8183.2011.00705.x","archive":["Portico"],"relation":{},"ISSN":["0896-4327","1540-8183"],"issn-type":[{"type":"print","value":"0896-4327"},{"type":"electronic","value":"1540-8183"}],"subject":[],"published":{"date-parts":[[2012,2,20]]}}}